NSE filing, NSE: AATMAJ. Summary written from the filing by ALFA Finder's alert engine.
Aatmaj Healthcare Ltd: key numbers
- Share price
- ₹23.50
- Market cap
- ₹53.11 Cr
- Revenue (annual)
- ₹24.32 Cr
- Net profit (annual)
- ₹0.71 Cr
- P/E (TTM)
- 74.5×Sector 52.3×
- Promoter holding
- 64.48%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aatmaj Healthcare Ltd
All →Aatmaj Healthcare Results Update
Aatmaj Healthcare reported H1 FY27 revenue of Rs. 16.96 crore and EBITDA of Rs. 2.04 crore. The company targets 80% revenue growth for FY27.
Aatmaj Healthcare Investor Presentation: Key Takeaways
H1 FY27 total revenue ₹1,738.52 lakh, up 54% YoY, while PAT fell about 28% to ₹36.95 lakh on finance and staff costs. Management guides H2 revenue up about 40% and FY27 PAT up about 80%.
- Call
- Guides 80% growth
Aatmaj Healthcare H1 FY27 Results: Net Profit ₹0.4 Cr, Down 20.0% YoY
Aatmaj Healthcare reported half-year total revenue of Rs 1,738.52 lakh and profit of Rs 36.95 lakh. Results are unaudited, with a clean limited review.
- Key figure
- Net profit ₹0.4 Cr · -20.0% YoY
Aatmaj Healthcare Board Meeting Date
Aatmaj Healthcare will hold a board meeting on October 29, 2026, to consider the company's un-audited standalone financial results for the half year ending September 30, 2026.
Aatmaj Healthcare Other Announcement
Aatmaj Healthcare filed its Reg 13(3) quarterly investor grievances report for Q2 FY27. All complaint counts (received, resolved, pending) were zero.
Aatmaj Healthcare Annual General Meeting
Aatmaj Healthcare Limited concluded its 12th Annual General Meeting on September 17, 2026. Shareholders adopted the audited financial statements for the year ended March 31, 2026.
Other other announcement announcements
All →STL Networks Other Announcement
The Monitoring Agency reported Rs. 2 Crore utilization of Preferential Issue proceeds, with no deviations from objects. The report covers the quarter ending September 30, 2026.
HEG Advanced Materials Other Announcement
HEG Advanced Materials Limited has intimated the exchange regarding the change of its Corporate Identification Number (CIN) following an approved scheme of arrangement.
Sanofi India Other Announcement
Sanofi India issued a communication regarding Tax Deduction at Source (TDS) for the interim dividend declared for FY 2026. Shareholders must update details by November 5, 2026.
Visaka Industries Other Announcement
Visaka Industries informed the exchange about sending reminder letters to shareholders regarding the compulsory transfer of unclaimed dividends and equity shares to the IEPF account.
Arvaya Healthcare Other Announcement
Arvaya Healthcare filed its quarterly shareholding pattern under Regulation 31(1)(c). The filing reports routine ownership breakdowns with no transaction.
AYM Syntex Other Announcement
AYM Syntex's board appointed BSR & Co. LLP as statutory auditor for five years, subject to shareholder approval. Routine auditor appointment; no monetary value involved.
- Execution
- Five consecutive years, from the conclusion of the 44th AGM to the conclusion of the 49th AGM